A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer

CONTEXT/OBJECTIVES: Pazopanib, an inhibitor of kinases including vascular endothelial growth factor receptor, demonstrated impressive activity in progressive metastatic differentiated thyroid cancer, prompting its evaluation in anaplastic thyroid cancer (ATC). DESIGN/SETTING/PATIENTS/INTERVENTIONS/O...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bible, Keith C., Suman, Vera J., Menefee, Michael E., Smallridge, Robert C., Molina, Julian R., Maples, William J., Karlin, Nina J., Traynor, Anne M., Kumar, Priya, Goh, Boon Cher, Lim, Wan-Teck, Bossou, Ayoko R., Isham, Crescent R., Webster, Kevin P., Kukla, Andrea K., Bieber, Carolyn, Burton, Jill K., Harris, Pamela, Erlichman, Charles
Format: Artigo
Langue:Inglês
Publié: Endocrine Society 2012
Sujets:
Endocrine Care
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3431569/
https://ncbi.nlm.nih.gov/pubmed/22774206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2012-1520
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires